(Bloomberg) The stock market’s closing bell has just rung on the third day of short seller Ben Axler’s campaign against Dexcom Inc. in late March, and things are going pretty much according to plan. That’s to say, things are going terribly for Dexcom.
The Tiny Activist Fund That Reaped 24% Return by Unearthing ‘Cockroaches
This entry was posted in Syndicated. Bookmark the permalink.